AllSight
Companies · MDLN · Surgical & Medical Instruments & Apparatus · Company update · Aug 5, 2026

Revenue and adjusted EPS beat, but full-year profit outlook falls.

Medline Inc. (MDLN) — what happened, in plain English, and what it means versus what the market expected.

The quarter cleared published estimates, but the beat is not the main message. Revenue of $7.69 billion narrowly exceeded the published consensus of about $7.67 billion, while adjusted diluted EPS of $0.50 was well above the published $0.32 expectation. But the earnings outperformance was materially aided by a $243 million net IEEPA tariff-refund benefit recorded in the quarter—an unusual, non-recurring gain that remains in adjusted results. (Financial Highlights; Adjusted Net Income Reconciliation)

MetricQ2 2026Q2 2025Expectation / prior outlook
Net sales$7.685B$6.886BPublished consensus: ~$7.67B (Financial Highlights)
Organic sales growth11.5%—— (Organic Sales table)
Adjusted EBITDA$1.060B$935MIncludes $243M net tariff-refund benefit (Adjusted EBITDA Reconciliation; IEEPA tariff-refund disclosure)
Adjusted diluted EPS$0.50—Published consensus: ~$0.32 (Adjusted Net Income Reconciliation)
GAAP net income$139M$333MDown 58.3% year over year (Income Statement)
Full-year organic-sales growth outlook9.0%–10.0%—Prior: 8.5%–9.5% (2026 Outlook)
Full-year adjusted EBITDA outlook$3.3B–$3.4B—Prior: $3.5B–$3.6B (2026 Outlook)

The forward outlook is a meaningful reset, not a routine tweak. Management raised its organic-sales growth range by 50 basis points at both ends, confirming demand is stronger than previously assumed. Yet it cut full-year adjusted EBITDA by $200 million at the midpoint, citing higher inflation tied to the Middle East conflict, added operating investment, quality-remediation work, and softer retail demand. Crucially, the new EBITDA outlook excludes tariff-refund benefits, so the lowered range is a cleaner indication of underlying profit pressure. (2026 Outlook)

Profitability weakened beneath the top-line growth. Sales rose 11.6% and gross margin improved 110 basis points to 28.8%, but operating income fell 38.5% and operating margin contracted to 5.1% from 9.3%. Selling and administrative expense rose 20.7%, while other operating expense jumped by $334 million, largely reflecting the Tracy distribution-center fire. The company recorded a $336 million fire loss before expected insurance recoveries; the filing does not quantify the eventual recovery or timing. (Income Statement; Other Non-Core Charges footnote)

The adjusted-profit headline needs context. Adjusted EBITDA rose 13.4%, but the $243 million tariff refund was larger than the $125 million year-over-year increase in adjusted EBITDA. Excluding that benefit, quarter adjusted EBITDA would have been roughly $817 million, below the prior-year $935 million—illustrating why the guidance cut outweighs the reported adjusted EPS beat. This is an inference from the disclosed EBITDA reconciliation and tariff-refund disclosure. (Adjusted EBITDA Reconciliation; IEEPA tariff-refund disclosure)

Cash generation and leverage remain offsets, rather than a cure for the outlook cut. First-half operating cash flow increased 28.2% to $1.13 billion and free cash flow rose 37.1% to $920 million. Net leverage stood at 2.9x, with $10.1 billion of net debt. That liquidity and cash conversion provide capacity to absorb disruption, but do not change the newly lower earnings framework for 2026. (Cash Flow Statement; Free Cash Flow table; Net Leverage table)

Read the original 8-K on SEC EDGAR ↗
All MDLN filings, decoded →
Related companies in Surgical & Medical Instruments & Apparatus
Latest across the market
ACNAccenture earnings beat as Q4 revenue clears guidance, but FY27 growth stays measuredROPRoper Technologies adds NTT DATA CEO to board, but brings no operating changeIIPRIIPR loan increase funds Alewife buildout, but locks in 14% debtGLUEMonte Rosa GFORCE-1 results clear safety bar, but ASCVD Phase 2 moves to 2027SMASmartStop dividend holds at $1.60 annualized as October payout repeats patternHBNCHorizon Bancorp schedules Q3 earnings, offering no fresh business readBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.
Analysis by AllSight · Editorial standards & method · Contact